Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome

Abstract

Tumors exhibit genomic and phenotypic heterogeneity, which has prognostic significance and may influence response to therapy. Imaging can quantify the spatial variation in architecture and function of individual tumors through quantifying basic biophysical parameters such as CT density or MRI signal relaxation rate; through measurements of blood flow, hypoxia, metabolism, cell death, and other phenotypic features; and through mapping the spatial distribution of biochemical pathways and cell signaling networks using PET, MRI, and other emerging molecular imaging techniques. These methods can establish whether one tumor is more or less heterogeneous than another and can identify subregions with differing biology. In this article, we review the image analysis methods currently used to quantify spatial heterogeneity within tumors. We discuss how analysis of intratumor heterogeneity can provide benefit over more simple biomarkers such as tumor size and average function. We consider how imaging methods can be integrated with genomic and pathology data, instead of being developed in isolation. Finally, we identify the challenges that must be overcome before measurements of intratumoral heterogeneity can be used routinely to guide patient care. Clin Cancer Res; 21(2); 249-57. Ó2014 AACR.

Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images

“…The differential contrast afforded by multiparametric MR imaging has not been exploited to its full potential. Several preliminary studies have begun to address these issues, and initial results appear promising (15)(16)(17).…”

“…While similar data-driven approaches have been proposed, they usually rely on simple thresholding or clustering techniques that are solely based on signal intensity patterns and, consequently, yield nonintuitive results with widely dispersed and intermingled subregions (15)(16)(17). These approaches are also limited by technical factors, such as image noise and artifacts.…”

Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment

“…There is an overall agreement in considering tumor heterogeneity as one of the key factors of the disease. It is directly related to some tumor properties and reflects its ability to respond/escape to therapeutic treatments [4,27]. Conversely, the values of the DCE-MRI estimates are therefore strongly dependent on how the tumor ROIs are drawn and on the applied statistic analysis.…”

Whole-lesion apparent diffusion coefficient (ADC) metrics as a marker of breast tumour characterization—comparison between ADC value and ADC entropy

“…Many mathematical models have been developed and employed to analyze tumour heterogeneity; whole-lesion histogram analysis is one of the most popular methods. 30,31 The development of post-processing platforms has made histogram analysis easier and less time-consuming. The method holds a great potential, even though there are still many challenges to be addressed until its role in tumour characterization is established in everyday practice.…”